Follow along with the video below to see how to install our site as a web app on your home screen.
Nota: This feature may not be available in some browsers.
thecrow ha scritto:sopra 2,15 proverei anche se e' tirata
moorecat ha scritto:4,80$
Low-Priced Stocks. Instinct tells me that StemCells Inc. (Nasdaq: STEM) is going to be a wildly volatile "story" stock that has to be watched every minute, especially now that it's planning a 7.5 million-share stock offering at a price lower than today's. StemCells does research aimed at developing therapies that would use stem and similar cells to treat and possibly one day cure Parkinson's and Alzheimer's diseases, multiple sclerosis, spinal cord injuries, stroke, hepatitis, chronic liver failure and diabetes. StemCells's edge for the time being is that it uses cells derived from fetal or adult tissue sources which at this moment is more or less legal; the company doesn't use embryonic stem cells, which is a type of research that gets no Federal funding yet. The company's third quarter loss widened by 79% to $4.3 million while revenue fell to almost nothing due to less grant money and a sole reliance on licensing agreements.Fabio.S ha scritto:cosa ne pensate
domino ha scritto:ocio!!!